FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely oncology and can be used for neoadjuvant treatments of stomach cancer that is ensured by intraarterial introduction of taxotere 75 mg/m2 and cisplatin 75 mg/m2 with selective catheterisation of celiac trunk. Regional chemotherapy in number of 2 to 4 courses is performed.
EFFECT: application of the invention enables higher operability and clinical effectiveness ensured by downsising of tumour and loc-regional metastases.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PERSONALIZED NEOADJUVANT INTRA-ARTERIAL CHEMOTHERAPY OF GASTRIC CANCER | 2021 |
|
RU2797397C2 |
CHEMOTHERAPY MODE IN HEPATIC METASTASES OF GASTRIC CARCINOMA | 2008 |
|
RU2364397C1 |
CERVICAL CANCER NEOADJUVANT CHEMOTHERAPY METHOD | 2009 |
|
RU2405544C1 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
METHOD OF STOMACH CARCINOMA TREATMENT | 1996 |
|
RU2134549C1 |
METHOD OF ADJUVANT THERAPY OF LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2465843C1 |
METHOD OF TREATING MALIGNANT GASTRIC AND DUODENAL TUMOURS | 2010 |
|
RU2436605C1 |
METHOD OF TREATING LOCALLY ADVANCED STOMACH CANCER WITH HIGH METABOLIC AND PROLIFERATIVE ACTIVITY | 2014 |
|
RU2552289C1 |
METHOD OF TREATING SIGNET RING CELL STOMACH CARCINOMA | 2010 |
|
RU2428993C1 |
METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
Authors
Dates
2009-11-20—Published
2008-06-16—Filed